Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
367 studies found for:    "Mycosis fungoides"
Show Display Options
Rank Status Study
21 Terminated Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
Condition: Lymphoma
Interventions: Drug: bexarotene;   Drug: methoxypsoralen;   Procedure: UV light therapy
22 Not yet recruiting Naloxone Hydrochloride Study for Relief of Pruritus in Patients With Mycosis Fungoides (MF) Form of CTCL
Conditions: Mycosis Fungoides;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: Naloxone Hydrochloride Lotion, 0.5%;   Drug: Placebo Lotion
23 Completed
Has Results
Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides
Condition: Lymphoma
Intervention: Radiation: TSEBT
24 Active, not recruiting Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome
Conditions: Recurrent Mycosis Fungoides and Sezary Syndrome;   Stage IB Mycosis Fungoides and Sezary Syndrome;   Stage IIA Mycosis Fungoides and Sezary Syndrome;   Stage IIB Mycosis Fungoides and Sezary Syndrome;   Stage IIIA Mycosis Fungoides and Sezary Syndrome;   Stage IIIB Mycosis Fungoides and Sezary Syndrome;   Stage IVA Mycosis Fungoides and Sezary Syndrome;   Stage IVB Mycosis Fungoides and Sezary Syndrome
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
25 Not yet recruiting Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Interventions: Drug: 3.75% Imiquimod Cream;   Drug: 0.1% Fluocinonide Cream
26 Completed Interleukin-2 in Treating Patients With Mycosis Fungoides
Condition: Lymphoma
Intervention: Biological: aldesleukin
27 Completed Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
Condition: Lymphoma
Intervention: Drug: pegylated liposomal doxorubicin hydrochloride
28 Terminated Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage I Mycosis Fungoides/Sezary Syndrome;   Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage II Mycosis Fungoides/Sezary Syndrome;   Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage III Mycosis Fungoides/Sezary Syndrome;   Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;   Stage IV Mycosis Fungoides/Sezary Syndrome
Interventions: Biological: aldesleukin;   Biological: recombinant interleukin-12;   Other: laboratory biomarker analysis
29 Unknown  Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate
30 Active, not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma;   Lymphoma, Primary Cutaneous Anaplastic Large Cell;   Lymphomatoid Papulosis;   Mycosis Fungoides;   Skin Lymphoma;   Cutaneous Lymphomas;   Lymphoma;   Hematologic Disorder
Intervention: Drug: SGN-35
31 Recruiting Early Diagnosis of Mycosis Fungoides
Condition: Cutaneous T Cell Lymphoma
Intervention: Other: Blood sampling
32 Recruiting Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Conditions: Solid Tumors;   Mycosis Fungoides;   Melanoma;   Merkel-cell Carcinoma;   Squamous Cell Carcinoma;   Breast Carcinoma;   Human Papillomavirus-Related Malignant Neoplasm;   Soft Tissue Sarcoma
Intervention: Drug: TTI-621
33 Terminated Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Drug: temozolomide
34 Completed Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Drug: tretinoin
35 Terminated Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Condition: Lymphoma
Intervention: Biological: aldesleukin
36 Active, not recruiting Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
Condition: Lymphoma
Intervention: Biological: alemtuzumab
37 Terminated Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
Conditions: Cutaneous Lymphoma;   Cutaneous T-cell Lymphoma
Interventions: Procedure: TSEBT;   Drug: Vorinostat
38 Recruiting Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas
Conditions: Lymphoma, T-Cell, Cutaneous;   Mycosis Fungoides
Interventions: Drug: Methotrexate;   Drug: Interferon Alfa-2b
39 Not yet recruiting Cell-free Circulating DNA in Primary Cutaneous Lymphomas
Conditions: Mycosis Fungoides;   Lymphoma, Large B-cell, Diffuse
Intervention: Genetic: Cytogenetic and molecular studies
40 Recruiting T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Conditions: Psoriasis;   Mycosis Fungoides

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.